Top Tech Companies in Belfast (535)

Strong Market Position & Advantage: Adoption among major insurance brokers is described as deep, with 8 of the 10 largest U.S. brokers and many top-ranked agencies using an Applied system in 2025. Recognition such as Applied Epic’s inclusion in G2’s 2026 Top 100 and a large installed base reinforce a leading position in agency/broker management software.

Innovation-Driven Growth: Product expansion through AI-focused acquisitions such as Planck (2024) and Cytora (2025) adds risk digitization and automation capabilities. New offerings like Applied Recon, rapid growth in Applied Pay usage, and a “submissionless” experience with Travelers indicate active innovation driving usage.

Investor Backing & Capital Strength: Long-term backing from Hellman & Friedman, alongside Stone Point Capital, JMI Equity, and CapitalG, supports ongoing investment capacity and M&A. Multi-year ownership since 2014 aligns with continued acquisitions and product expansion.

Profitability: Financial results indicate rising earnings, with full-year net income higher year over year and additional gains in subsequent quarters. EPS and returns improved as lending and fee-based businesses strengthened after regulatory constraints eased.

Market Expansion: The lifting of the Federal Reserve’s asset cap enabled renewed balance-sheet growth, reflected in higher loans, deposits, and total assets. Growth is described as broadening across cards, auto lending, commercial banking, investment banking, and wealth management.

Cost & Operational Efficiency: Operations are being streamlined through headcount reductions and branch optimization, supporting better efficiency and operating leverage. These actions have coincided with increased dividends and share repurchases.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Product Line Growth: Product scope has widened beyond core clearing/custody, with launches such as Apex Ascend (real-time, cloud-native infrastructure), Apex Alts, and new capabilities like AI tools, prediction markets, and direct indexing, plus acquisitions including FinTron and AdvisorArch. These additions indicate a broader platform designed to serve more wealth-tech workflows and asset types.

Strategic Partnerships: Recent announcements highlight collaborations with major platforms and institutions, including Cash App Investing selecting Apex as a strategic clearing platform, Gemini choosing Apex for U.S. stock-trading custody/clearing, and integrations/alliances with Plaid, Google Cloud, and State Street. These relationships point to expanding distribution and external validation of the offering.

Strong Market Position & Advantage: Operating scale is substantial, with company-reported figures of hundreds of billions in assets under custody, tens of millions of accounts, and hundreds of millions of annual trades, alongside support for 200+ platforms. High-profile platform selections reinforce a durable position in digital investing infrastructure.

Strong Revenue Growth: Annual recurring revenue is described as rising sharply over recent periods with continued uplift into the following year. These signals point to a scaling recurring-revenue model rather than one-off sales.

Market Expansion: Hundreds of new customer logos were added across successive years, with net customer growth and significant increases in cloud usage across regions such as Asia and ANZ. This reflects expansion beyond North America and deeper penetration within the installed base.

Innovation-Driven Growth: Rapid cloud migration and the rollout of AI capabilities (e.g., Ask iManage, AI Enrichment, Insight+) are portrayed as key adoption catalysts. These innovations appear to be driving multi-solution uptake and greater platform stickiness among enterprises.

Strong Revenue Growth: Company-reported metrics indicate monthly revenue doubled over 24 months and subscription revenue increased fourfold within 12 months. Net revenue retention reached 100% in 2023, signaling expansion of recurring relationships.

Investor Backing & Capital Strength: The business secured a $14M Series C in July 2025, bringing total disclosed funding to roughly $41.7M across five rounds. Independent industry tracking in 2025 also records the round, indicating continued access to institutional capital.

Product Line Growth: The 2025 launch of the Ascend human‑risk platform and subsequent modules reflect expansion beyond managed‑intelligence services into a broader platform offering. Current positioning spans executive protection, insider‑threat intelligence, employment‑fraud detection, third‑party intelligence, and digital exposure monitoring.

Strong Market Position & Advantage: Adoption spans 1,300+ biotechnology organizations with usage reported across more than half of the top 50 biopharma companies, signaling durable positioning in life‑sciences R&D software. Multiple sources characterize the platform as a leading life‑sciences R&D cloud used by both startups and major enterprises.

Product Line Growth: The company continues to launch and expand major offerings, including Benchling AI, antibody‑discovery capabilities, automation/analysis tools, and extensions into new scientific workflows such as small‑molecule chemistry. Acquisitions like PipeBio further broaden capability depth in biologics and related R&D domains.

Innovation-Driven Growth: AI is a clear growth vector, with reports that 500 biotech companies used Benchling AI in its first year and the product subsequently reached general availability. Team acquisitions (e.g., ReSync Bio and Sphinx Bio) and partnerships (e.g., with Anthropic) underscore a deliberate push to embed advanced models into scientific workflows.

Strong Revenue Growth: Historical metrics indicate rapid scaling, with gross revenue rising from under $300M in 2018 to roughly $900M in 2020. Platform volume also surpassed $2B in 2019 alongside very strong year-over-year growth at that time.

Investor Backing & Capital Strength: The company secured major financings, including $300M rounds in 2019 and 2021 at valuations of about $1.9B and $2.9B, bringing total funding above $750M. These rounds signal strong investor confidence during periods when the business was scaling across customers and service categories.

Product Line Growth: Offerings expanded beyond a labor marketplace into an energy-specific source-to-pay and vendor management platform, with additions such as bid management, technology licensing, and an engineering acquisition. Recent moves like launching vendor management, licensing Shell’s U‑lateral technology, and acquiring Codeco‑Vanoco Engineering suggest ongoing product and capability expansion.

Profitability: Feedback suggests profitability is strengthening with record margins and double‑digit EPS growth alongside guidance raises as of Q2 FY2026. Independent coverage also characterized the print as “record‑breaking performance,” reinforcing earnings momentum.

Resilient & Sustainable Growth: Feedback suggests underlying growth is durable, evidenced by a record and rising backlog with management raising full‑year guidance. Calendar and award‑timing headwinds are already embedded in outlook, indicating resilience despite near‑term noise.

Strong Market Position & Advantage: Feedback suggests AECOM’s consistent top industry rankings and global scale reinforce a competitive edge that supports demand capture. Recognition as the world’s top design firm in multiple sectors underpins its ability to win and retain large programs.

Strong Market Position & Advantage: Bazaarvoice is broadly viewed as a leader in commerce-focused UGC syndication, anchored by what it markets as the largest brand-to-retailer content network. Consistent category recognition and retailer adoption underline durable competitive advantage.

Strategic Partnerships: Retail and ecosystem alignments such as Walmart, JCPenney’s visual syndication participation, and Shipt joining the network indicate deep channel ties and expanding distribution endpoints. These relationships reinforce network effects that attract large brands and retailers.

Product Line Growth: Acquisitions of Influenster, Curalate, affable.ai, and Granify extend the offering into visual/social UGC, creator marketing, sampling, and AI-driven onsite personalization. New launches like Vibe and HarmonyAI signal continued portfolio expansion.

Strong Revenue Growth: Feedback suggests revenue has surpassed key milestones, including exceeding £100 million and scaling to over £200 million following the combination with Kreston Reeves.

Strategic Partnerships: Feedback suggests major combinations and acquisitions, including Kreston Reeves and GS Verde, have expanded scale and capabilities across 23 locations.

Investor Backing & Capital Strength: Feedback suggests backing from Goldman Sachs Alternatives has provided capital to accelerate acquisitions, talent investment, and technology initiatives.

Strong Market Position & Advantage: Diageo is consistently depicted as the global leader in international spirits, with category leadership in Scotch and tequila and Johnnie Walker’s category-topping status anchoring that edge. Scale and global reach provide durable share and pricing power even through cycles.

Strong Brand Reputation: Iconic, globally recognized brands such as Johnnie Walker, Guinness, Smirnoff, and Don Julio, alongside independent brand‑valuation mentions, support resilient brand equity. Company materials emphasize a brand‑led strategy that sustains pricing and share through continued investment.

Healthy Cash Flow: Management targeted roughly $3 billion of free cash flow for FY26 despite softer top‑line trends. An accelerated multi‑year cost‑savings program is intended to support cash generation and financial flexibility.

Profitability: Results highlight robust returns and earnings, indicating strong franchise economics versus many peers. Recent updates point to continued delivery into 2026.

Strong Market Position & Advantage: Independent awards and industry context point to leadership in UK corporate banking and a top‑tier position in core lending such as mortgages. The group sits in the leading cohort of UK incumbents with distinctive strength in SMEs and corporates.

Diversified Revenue Streams: Strategic moves into wealth management and selected portfolio acquisitions are positioned to expand fee income and balance interest‑driven revenues. Management frames these actions as accretive to growth and returns.

Strong Market Position & Advantage: Analyst reports in 2025 place Harness as a Leader in Gartner’s Magic Quadrant and Forrester’s Wave for DevOps Platforms, signaling top-tier standing among end-to-end platforms. Coverage also highlights expansion beyond CD into feature flags, security/test orchestration, cloud cost, and IDP.

Strong Revenue Growth: Public statements note crossing $100M ARR in 2023/2024 and being on track to exceed $250M ARR in 2025, indicating robust momentum. Reported year-over-year growth into that period is characterized as strong and accelerating.

Investor Backing & Capital Strength: Funding events include a $240M Series E at a $5.5B valuation in December 2025 and a $150M credit facility in 2024, providing material capital for expansion. The valuation step-up and new capital are cited as signals of investor confidence.

Product Line Growth: Solutions revenue expanded sharply and now represents a substantial share of the business. Higher-value digital packages are gaining traction, with average revenue per customer rising and most new sales coming from this segment.

Cost & Operational Efficiency: Margins and EBITDA were maintained or modestly improved despite top-line contraction through strict overhead reductions and targeted capex cuts. Leaner execution is helping to stabilize profitability during the transition.

Healthy Cash Flow: Operating cash generation improved while revenue declined. Stronger cash conversion is supported by cost discipline and a mix shift toward higher-margin offerings.